Edition:
India

People: Aptinyx Inc (APTX.OQ)

APTX.OQ on NASDAQ Stock Exchange Global Select Market

3.77USD
4 Dec 2020
Change (% chg)

$-0.07 (-1.82%)
Prev Close
$3.84
Open
$3.80
Day's High
$3.85
Day's Low
$3.75
Volume
82,836
Avg. Vol
251,556
52-wk High
$6.47
52-wk Low
$1.61

Enright, Patrick 

Mr. Patrick G. Enright has been appointed as Independent Chairman of the Board of the Company effective 5/20/2020. Mr. Enright has served as a Managing Director of Longitude Capital, a venture capital firm, of which he is a founder. From 2002 through 2006, Mr. Enright was a Managing Director of Pequot Ventures, a venture capital investment firm, where he co-led the life sciences investment practice. He currently serves on the boards of directors of Aimmune Therapeutics, Inc., Jazz Pharmaceuticals plc, and several privately-held companies. During the past five years, Mr. Enright has served on the boards of directors of Esperion Therapeutics, Inc. and Corcept Therapeutics Incorporated. Mr. Enright received a B.S. from Stanford University and an M.B.A. from the Wharton School at the University of Pennsylvania. We believe Mr. Enright is qualified to serve on our board due to his experience as a venture capital investor focused on life sciences companies and his past work in the pharmaceutical industry.

Basic Compensation

Total Annual Compensation, USD 46,500
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 91,045
Fiscal Year Total, USD 137,545

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick Enright

137,545

Norbert Riedel

5,635,420

Ashish Khanna

2,124,730

Andrew Kidd

2,121,200

Henry Gosebruch

215,378

Elisha Gould

131,045
As Of  31 Dec 2019